Autopsy report · NCT02131272
A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal Insulin
Cause of deathNo reason given
Life of this trial
- Registered 1 month before it started.
- Ran for about 2 years before it stopped.
- 42 participants enrolled.
- Results were posted on the registry 1 year 3 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Novo Nordisk A/S
- Sponsor type
- Industry
- Conditions
- Diabetes; Diabetes Mellitus, Type 2
- Interventions
- Insulin detemir; Insulin NPH; Diet/exercise
- Participants
- 42
- Sites
- 82
- Countries
- Argentina, Brazil, Croatia, Egypt, Germany, Greece, Hungary, India, Israel, Italy, Lebanon, Malaysia and more
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.